NewLimit Blog
Brian Armstrong, Jacob C. Kimmel, Blake Byers, Cathy O'HareProgress reports from our work to develop epigenetic reprogramming medicines for aging
| Platform |  | Pricing | Only free issues | Publishes | Monthly |
|---|---|---|---|---|---|
| Issues | 36 | Subscribers | Read | blog.newlimit.com |
Curious about how many subscribers NewLimit Blog has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Latest Issues
Recent posts by this newsletter. Browse the email archive.
2025 Year in Review
We founded NewLimit in 2022 to develop reprogramming medicines that add happy, healthy years to people’s lives. We imagined it would take five years or more before our fundamental science was mature enough to start developing medicines.
September // October 2025 Progress Update
We are close to holding our first clinic-bound reprogramming medicine in hand. Scientists across each of our teams have spent the past several months building the final version of a therapeutic payload that restores youthful function in hep...
NewLimit has raised an additional $45M from Lilly, Duke University, Section 32, & Abstract on a $1.62B cap
Five months after closing our Series B, NewLimit has raised an additional $45M from Eli Lilly and Company, Duke Management Co, Section 32, and others on a $1.62B cap. Insiders including Kleiner Perkins, Dimension, Abstract, Human Capital, a...
July // August 2025 Progress Update
We’ve spent the latter months of summer moving our most advanced prototype medicines from discovery toward development. Our most recent data have convinced us that we’re on track to launch a human trial in the coming years, and these are th...
Authors
The writers behind this newsletter.
Co-founder and CEO at Coinbase
Co-founder & President @ NewLimit
building and investing in tech + biotech companies // prev partner @GVteam, @Stanford PhD
Scientist by training; generalist by nature. Head of Ops at NewLimit.
Frequently Asked Questions
How can I access the email archive for NewLimit Blog?
You can find recent issues that have been published by NewLimit Blog on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does NewLimit Blog have?
To see how many people subscribe to NewLimit Blog, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in NewLimit Blog?
Newsletter advertising can be extremely effective when it's done right. Before you pitch NewLimit Blog as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like NewLimit Blog?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact NewLimit Blog using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to NewLimit Blog?
Scroll up to where it says Similar Newsletters to see other publications like NewLimit Blog. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact NewLimit Blog?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.